Orthogonally conjugated phthalocyanine-porphyrin oligomer for NIR photothermal-photodynamic antibacterial treatment

Orthogonally conjugated phthalocyanine-porphyrin oligomer for NIR photothermal-photodynamic antibacterial treatment

Introduction

The rapid growth of antibiotic resistance has seriously threatened human health worldwide due to the overuse of antibiotic in public health and food industries1,2,3. Over the past few decades, conventional antibiotics have shown growing ineffectiveness in treating some infections in hospitals4. For example, as reported by US National Institutes of Health, the number of methicillin-resistant Staphylococcus aureus strains (t002) has increased significantly since 20135. However, antibiotics are still the primary clinical treatment for bacterial infections. Furthermore, the shortage of novel antibiotics is exacerbating these public health issues4,6,7. Therefore, the development of new antibacterial agents and methods with high efficiency, safety and convenience has been urgently put on the agenda8,9,10,11,12.

Light-induced phototherapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), have attracted more and more interest in anticancer and antibacterial treatment due to their unique noninvasiveness, minimal side effects and wide range of adaptability13,14,15,16,17,18,19. Comparing with conventional antibiotic treatment, both PDT and PTT enable repetitive treatments without dosage limitation and risk of drug resistance, although they are based on different therapeutic mechanisms. In PDT, highly reactive oxygen species (ROS) were produced by photon excited photosensitizer (PS) to exterminate bacteria20,21,22,23; In PTT, light triggers the photothermic agent (PTA) to produce heat, which then induces damage or death of bacteria24,25,26,27. Its oxygen-independent nature endows it with decent therapeutic efficacy against anaerobic bacteria in hypoxia environment (Supplementary Fig. 1). The combined use of PDT and PTT for cancer treatment has shown enormously enhanced therapeutic efficacy28,29,30,31,32, which is not only due to the therapeutic effect superposition of PDT and PTT, but also PTT heat can improve oxygen concentration through accelerating blood flow to make up the oxygen consumption of PDT. In term of the similar replication rate and highly uptake capability of cancerous cells and bacteria33, PDT and PTT have the same therapeutic effect on them. Whereas, the antibacterial studies on either PDT or PTT are far behind that for anticancer treatment. In particular, the combined PDT-PTT antibacterial studies have been rarely reported.

So far, various materials have been developed for PDT and PTT, such as carbon-based nanoparticles34,35, gold nanoparticles36,37,38, metal compounds39,40,41 and organic dyes42,43,44, etc. Among these materials, porphyrin (Por)45,46 and phthalocyanine (Pc)47,48,49 have been extensively studied as either photosensitizer or photothermal agent based on different mechanisms, because of their extraordinary photophysical and photochemical properties as well as excellent stabilities and low toxicity. Compare to inorganic materials with long-term toxicity and low biocompatibility, Por is a class of natural compound that widely exist in organisms, participating in important biochemical processes of photosynthesis and oxygen-transport, which endow it with unique affinity for bacteria and cancerous cells50; On the other hand, Pc is the synthetic analog of Por, which shows much higher absorption than Por in red to NIR region that is considered as optimal therapeutic window for treatment deep-seated lesions51. In addition, silicon phthalocyanine (SiPc)52 with two axial ligands on the opposite sides of the Pc planar is recognized to be one of efficient PS for PDT because of its high ROS generation and excellent biocompatibility, of which the axial ligands can tremendously break the π-π interaction to enhance its solubility and photoactivity. In fact, photothermal effect of Por and Pc are mainly based on H-aggregation induced non-radiative vibration relaxation, however, at the expense of blue-shifted absorption, quenching of both fluorescence and PDT53,54,55 (Fig. S1). Accordingly, how to construct Pc and Por to maximize synergistic PDT-PTT therapeutic effect is of great challenge for researchers.

In the present work, an orthogonal conjugated oligomer between Por and Pc was design and constructed, starting from silicon phthalocyanine (SiPc-NH2) and 5,15-diphenyl-10,20-di(4-carboxyphenyl)porphine (ddCPP). The conjugation reaction between axial -NH2 and peripheral -COOH results in orthogonal structure between phthalocyanine and porphyrin (Fig. 1). The obtained SiPc-ddCPP exhibits good solubility both in organic and aqueous solvents due to the suppression of π-π aggregation, and remarkable NIR photothermal effect (η = 31.15%) accompanied with fluorescence emission and ROS generation. Antibacterial studies indicated that SiPc-ddCPP show bacterial-affiliated synergistic PDT-PTT therapeutic effect on both Gram-positive and Gram-negative anaerobic bacteria. These results suggest SiPc-ddCPP is a novel multifunctional NIR bactericide for PDT-PTT synergistic sterilization of both anaerobic and aerophile bacteria.

Fig. 1: Molecular structure.
Orthogonally conjugated phthalocyanine-porphyrin oligomer for NIR photothermal-photodynamic antibacterial treatment

Chemical structure of 5,15-diphenyl-10,20-di(4-carboxyphenyl)porphine (ddCPP), silicon phthalocyanine (SiPc-NH2) and orthogonal conjugate SiPc-ddCPP.

Full size image

Results and discussion

Synthesis and characterization of SiPc-ddCPP

As a macrocyclic conjugated planar architecture, phthalocyanine tend to employ face-to-face H-aggregation. Although the H-aggregates favor photothermal effect through non-radiative vibration relaxation, they are unstable in physiological environment due to the weak π-π interaction within the aggregate, leading to reduced PTT therapeutic efficiency. In addition, H-aggregation will induce blue-shifted absorption and quenching of both fluorescence and ROS generation, which not only inhibits the PDT effect but also weaken the tissue penetration by light. This competition nature between PDT and PTT greatly hinders the realization of their synergistic therapeutic effect. Our recent studies on phthalocyanine based photothermal materials indicated that the intramolecular energy transfer between different chromophores could significantly increase photothermal effect without quenching of fluorescence56. Herein, to achieve combined PDT-PTT effect, amide-bond connected hybrid oligomer (SiPc-ddCPP) featuring orthogonal configuration between silicon phthalocyanine and porphyrin was constructed with expectation of enhanced PTT effect without quenching of PDT and fluorescence. Firstly, starting material of SiPc-NH2 was synthesized by substitution of SiPcCl2 with 2-(2 aminoethoxy) ethanol using previously reported method57,58. Subsequently, SiPc-ddCPP was constructed between SiPc-NH2 and ddCPP through coupling of -NH2 and -COOH by EDC/NHS conjugation procedure with the SiPc-NH2/ddCPP molar ratio of 2:1. The reaction mixture was successively purified by dialysis in DMF and H2O (molecular weight cutoff: 1000) to remove unreactive starting materials and conjugation reagents. Finally, SiPc-ddCPP was obtained by freeze-drying as dark powder (Scheme 1). It worth to mention, after several attempts, optimal particle size of SiPc-ddCPP (~100 nm) could be obtained at the SiPc-NH2/ddCPP molar ratio of 2:1, which is used for the following biological application studies.

Scheme 1
scheme 1

Synthesis. Synthetic procedure of SiPc-ddCPP.

Full size image

Gel permeation chromatography (GPC) was used to determine the molecular weight and purity of SiPc-ddCPP. It can be seen from the outflow curve of GPC (Fig. 2a), the compounds were separated out at ~17 min, shown as a narrow sharp peak, which is corresponding to the molecular mass of Mwmax ~ 5200 in the molecular weight distribution curve (Fig. 2b). Accordingly, the condensation number in SiPc-ddCPP is calculated to be n ≈ 4. Atomic absorption spectrum (AAS), a method to qualitative and quantitative analysis of element by its characteristic absorbance, was used to further evaluate the purity of SiPc-ddCPP. The Si content was detected to be 0.2825 mg L-1 in SiPc-ddCPP (1 μM per unit) with a small 0.53% deviation from the theoretical value of 0.2810 mg L-1, showing the good purity of SiPc-ddCPP (Supplementary Fig. 2). The particle size distribution of SiPc-ddCPP in H2O was detected by dynamic light scattering (DLS) method. As shown in Fig. 2d, the particle size of SiPc-ddCPP is ca.100 nm, locating at the optimal particle range for biological studies. In addition, thermogravimetric analysis (TG) shows that SiPc-ddCPP start to decompose at 311 °C and exhibit the good thermostability of SiPc-ddCPP.

Fig. 2: Molecular and size distribution.
figure 2

The (a) effluent curve and (b) molecular weight distribution map of SiPc-ddCPP in GPC; (c) TG curve of SiPc-ddCPP; (d) DLS analysis of SiPc-ddCPP in H2O.

Full size image

The bond formation was characterized by Fourier transform infrared (FT-IR) spectra, Raman spectroscopy and X-ray photoelectron spectroscopy (XPS). As shown in FT-IR spectrum of SiPc-ddCPP, the νC=O(OH) absorption at 1692 cm-1 from ddCPP disappeared and replaced by the absorption at 1624 cm−1 attributed to νC=O(NH), indicating the successful formation of amide bond between SiPc and ddCPP. The Raman spectra of SiPc-NH2, ddCPP and SiPc-ddCPP are compared in Fig. 3b. A superimposing of Raman signals of SiPc-NH2 and ddCPP was observed in SiPc-ddCPP spectrum and the weak signals of ddCPP were overlapped by that of SiPc-NH2, indicating the coexistence the two components. The XPS spectrum of SiPc-ddCPP also exhibit the photoelectrons of Si 2p, C 1 s, N 1 s, and O 1 s, coming from both SiPc-NH2 and ddCPP, further confirming the successful synthesis of the hybrid oligomer between the two components (Fig. 3).

Fig. 3: Bond formation characterization.
figure 3

a FT-IR spectra, (b) Roman spectra and (c) XPS spectra of SiPc-NH2, ddCPP and SiPc-ddCPP.

Full size image

Moreover, the covalent amide bond formation was further characterized by comparison the core-level high-resolution photoelectrons spectra of C 1 s and N 1 s between SiPc-NH2/ddCPP and SiPc-ddCPP. The N 1 s high-resolution spectrum of SiPc-NH2 can be curve-fitted three peaks corresponding to nitrogen functional groups of C = N (399.05 eV), C-N (400.60 eV), and N-H (402.29 eV). For comparison, the N 1 s high-resolution spectra of SiPc-ddCPP fit four peaks corresponding to the nitrogen functional groups of C = N (398.30 eV), C-N (399.61 eV), N-H (400.71 eV) and O = C-N (403.04 eV), respectively. The appearance of new peak of O = C-N (403.04 eV) is a good proof for the formation of amide bonds. In addition, the high-resolution electronic spectrum of C 1 s were also analyzed. The C 1 s high-resolution spectrum of ddCPP was fitted with five peaks. They correspond to the carbon functional groups of C-C/C = C (284.60 eV), C-N/C = N (285.90 eV), C-O (286.62 eV), C = O (288.19 eV), O-C = O (289.66 eV), respectively. Contrastively, the C 1 s high-resolution spectrum of SiPc-ddCPP was also fitted with five peaks. They correspond to the carbon functional groups in C-C/C = C (284.64 eV), C-N/C = N (285.93 eV), C-O (287.08 eV), C = O (288.88 eV) and N-C = O (290.51 eV). The O-C = O (289.66 eV) peak belonging to ddCPP disappears and instead by the N-C = O (290.51 eV) peak of SiPc-ddCPP, which strongly proves the formation of amide bond (Fig. 4).

Fig. 4: XPS analysis.
figure 4

N 1 s XPS spectra of (a) SiPc-NH2 and (b) SiPc-ddCPP; C 1 s XPS spectra of (c) ddCPP and (d) SiPc-ddCPP.

Full size image

The fluorescence and UV-Vis absorption spectra were performed in both DMF and aqueous solution for comparison. As shown in Fig. 5, the absorption curve of SiPc-ddCPP in DMF shows the characteristic peaks from monomeric SiPc and ddCPP, indicating the coexistence of both chromophores. In addition, the absorption peaks of ddCPP fall right into the absence region of Pc, resulting in a fully absorption spectrum ranging from ultraviolet to NIR region. Due to the existence of ethylene glycol linkage chains in SiPc-ddCPP, along with its orthogonal structure, excellent dispersity in aqueous solutions was observed. The characteristic absorption of SiPc and ddCPP can be observed in H2O and biological PBS for SiPc-ddCPP, revealing its good solubility and the advantage of orthogonal structure of SiPc-ddCPP to prevent π-π aggregation in water. Comparing to the absorption in DMF, a more than 3 times higher NIR absorption can be detected due to its relatively less dispersion in aqueous environment. However, in turn, this is favorable to the NIR photothermal potential for treatment of deep-seated infections. The excitation-emission relationship of fluorescence is an indirect method to detect intramolecular energy transfer. As shown in Supplementary Fig. 3, intense fluorescence attributed to SiPc (~675 nm) could be detected for SiPc-ddCPP under excitation by either SiPc or ddCPP absorption, strongly manifesting the energy transfer from ddCPP to SiPc within SiPc-ddCPP. At equivalent concentration, the relative lower fluorescence intensity of SiPc-ddCPP than free SiPc-NH2 to further evidenced the intramolecular energy loss during transfer process within SiPc-ddCPP. Furthermore, both the absorption and fluorescence intensities are proportional concentration dependent, indicating the good purity and stability of SiPc-ddCPP in solution.

Fig. 5: Absorption spectra.
figure 5

a UV-vis absorption of equivalent SiPc-ddCPP, ddCPP, and SiPc-NH2 in DMF; UV-vis absorption of SiPc-ddCPP at different concentrations in (b) DMF, (c) H2O and (d) PBS.

Full size image

Time-resolved fluorescence is employed as direct method to further explore the intramolecular energy exchanges. It can be seen from Supplementary Fig. 4, the fluorescence lifetime of SiPc-NH2 and ddCPP are 6.59 ns and 11.05 ns, respectively, while the fluorescence lifetime of SiPc-ddCPP is significantly reduced to 2.95 ns, due to the energy transfer between the two chromophores.

Singlet oxygen (1O2) generation

The effectiveness of photodynamic therapy is the capability to produce singlet oxygen (1O2). Indirect method using DPBF as 1O2 trapping agent was used to evaluate the photodynamic properties of SiPc-ddCPP. It can be seen in Fig. 6, with coexisting of SiPc-ddCPP, the absorption of DPBF at 415 nm gradually reduces along with the irradiation time by red light (λ > 610 nm), showing 1O2 is continually generated. For comparison, the 1O2 generation efficiencies in NIR region was also detected under irradiation by NIR light (λ = 750±10 nm) and it was found that 1O2 could also be generated by SiPc-ddCPP. These data clearly shows that the orthogonal structure of SiPc-ddCPP is beneficial to 1O2 generation and photodynamic therapy. The singlet oxygen yield of SiPc-ddCPP was calculated to be ΦΔ = 0.17 using ZnPc as reference, which is less than half of that of SiPc-NH2 (ΦΔ = 0.37), due to the energy exchange induced nonradiative heat relaxation caused reduced intersystem crossing pathway. In addition, type II mechanism was determined to be the main PDT pathway for SiPc-ddCPP (Supplementary Fig. 5).

Fig. 6: Singlet oxygen generation.
figure 6

UV-vis absorption spectra for the determination of 1O2 from SiPc-ddCPP irradiated by (a, c) red light (λ > 610 nm), (b, d) NIR light (λ = 750 ± 10 nm) in DMF (a, b) and water (c, d).

Full size image

Photothermal properties of SiPc-ddCPP

The photothermal properties of SiPc-ddCPP was tested under both 671 nm and 808 nm laser irradiation to evaluate the photothermal effect from red to NIR region. The strong NIR absorption of SiPc-ddCPP is conducive to convert NIR light into heat for photothermal therapy. To obtain the instinct photothermal response, SiPc-NH2, ddCPP, and SiPc-ddCPP were compared at low concentration. Under the same conditions (808 nm), the temperature increase of SiPc-ddCPP (ΔT ≈ 25.3 °C) is much higher than that of SiPc-NH2 (ΔT ≈ 16.7 °C) and ddCPP (ΔT ≈ 3.2 °C), strongly certifying that SiPc-ddCPP is an excellent NIR photothermal agent. Due to the absorption absence in NIR region, the temperature of ddCPP remains almost unchanged as control H2O (Fig. 7a).

Fig. 7: Photothermal analysis.
figure 7

a Thermal images of equivalent SiPc-NH2, ddCPP, SiPc-ddCPP in deionized water under 808 nm laser irradiation (3.5 W cm-2) and the corresponding time-dependent photothermal curves; (b) thermal images of SiPc-ddCPP at different concentrations under 808 nm laser irradiation (3.5 W cm-2) and the corresponding time-dependent photothermal curves; (c) thermal images of SiPc-ddCPP at different concentrations under 671 nm laser irradiation (3.5 W cm-2) and the corresponding time-dependent photothermal curves; (d) thermal images of SiPc-ddCPP (30 μM) at different 808 nm laser irradiation and the corresponding time-dependent photothermal curves.

Full size image

In contrast, SiPc-ddCPP also shows excellent photothermal response at 671 nm due to its high absorption in red region, which is comparable to the photothermal heating at 808 nm. The temperature of SiPc-ddCPP readily increase up to 65 °C under either 671 nm or 808 nm laser irradiation, exceeding the photoablation limit (50 °C) of living cells or bacteria, which convincingly show the remarkable PTT potential of SiPc-ddCPP from red to NIR region. In addition, the photothermal heating of SiPc-ddCPP was positively correlated with concentration and laser power as shown in Fig. 7. All these results exhibit that orthogonal structured SiPc-ddCPP has excellent photothermal capability for PTT from red to NIR region.

Photothermal stability and photothermal conversion efficiency

An excellent photothermal material should not only have good photothermal response and near-infrared absorption, but also have certain photostability. The photothermal stability of SiPc-ddCPP was verified by an experimental method of repeated heating/cooling cycles under high laser power irradiation (3.5 W cm-2). After five cycles, the heating rate and temperature increase of SiPc-ddCPP remain unchanged (Fig. 8a), which proves that SiPc-ddCPP possesses good photothermal stability and photobleaching resistance, making it a promising candidate for further clinical application. This is consistent with the good thermostability evaluated by thermogravimetric analysis as described above.

Fig. 8: Photostability analysis.
figure 8

a The stability cycles of SiPc-ddCPP aqueous solution under 808 nm laser irradiation (3.5 Wcm-2); (b) photothermal response of SiPc–ddCPP in H2O under laser irradiation (808 nm, 1.25 W cm-2) then light shut off and (c) plot of the cooling time vs. the negative natural logarithm of the driving force temperature obtained from the cooling stage.

Full size image

According to the published method58, the NIR photothermal conversion efficiency (η) of SiPc-ddCPP was calculated as 31.15%, which is much higher than most of inorganic and organic photothermal materials, such as Au nanorods59, Cu2-xSe nanomaterials60, MB61 and indocyanine green62. This efficient photothermal effect of SiPc-ddCPP in NIR region is in favor of PTT treatment of deep-seated infections. As aforementioned, both steady fluorescence and time-resolved fluorescence have successfully proved the efficient energy transfer between the two chromophores in SiPc-ddCPP. Hence, the enhanced non-radiative vibration relaxation and NIR absorption caused by intramolecular energy transfer in SiPc-ddCPP should jointly account for its remarkable photothermal conversion efficiency (Fig. 8).

Antibacterial experiment

Based on the good singlet oxygen generation and photothermal capability of SiPc-ddCPP, the PDT-PTT combined antibacterial studies were conducted on both Gram-positive bacteria (S. aureus) and Gram-negative anaerobic bacteria (E. coli). The colony counting method was used to evaluate the PDT, PTT or PDT-PTT antibacterial effect of SiPc-ddCPP. A 660 nm LED lamp and 808 nm laser were chosen for evaluated PDT and PTT efficacy, respectively. As can be seen from Fig. 9, SiPc-ddCPP is nontoxic to either S. aureus or E. coli bacteria in dark. In contrast, both S. aureus and E. coli could be efficiently inhibited under irradiation by either 660 nm LED lamp or 808 nm laser, showing its PDT and PTT antibacterial effect of SiPc-ddCPP. Due to an extra outer membrane of Gram-negative bacteria63, E. coli is less sensitive than S. aureus by either photodynamic or photothermal treatment, which is also observed by previously reported PDT/PTT antibacterial studies64. As expected, the combined application of PDT and PTT significantly improved the antibacterial efficacy and achieved 100% bacteria death of S. aureus and E. coli more easily than PDT or PTT alone (Fig. 9). Furthermore, the fluorescence of SiPc-ddCPP in S. aureus showed higher fluorescence intensity than that in E. coli, which was consistent with the antibacterial efficacy of SiPc-ddCPP, demonstrating that SiPc-ddCPP had a good affinity for bacteria and could be used for bacterial infections (Fig. 10).

Fig. 9: In vitro antibacterial activities.
figure 9

Antibacterial activity images (upper) and corresponding statistical analysis (lower) of SiPc-ddCPP against (a) Gram-positive bacteria (S. aureus) and (b) Gram-negative bacteria (E. coli) under irradiation of PTT, PDT and PTT-PDT.

Full size image
Fig. 10: Confocal fluorescence images.
figure 10

a S. aureus and (b) E. coli after being incubated with medium (upper) and SiPc-ddCPP (lower).

Full size image

The biocompatibility of SiPc-ddCPP was evaluated on mouse embryonic osteoblasts (MC3T3) cells (Supplementary Fig. 6). A 95% survival rate in dark and 86% survival rate post-irradiation with the concentrations up to 10 μM were observed, demonstrating the good biocompatibility of SiPc-ddCPP to normal healthy cells due to the lower uptake by normal cell than bacteria within the time for infection treatment. The octanol–water partition coefficient (logP) of SiPc-ddCPP also shows its good hydrophilicity (Supplementary Table 1). These results systematically exhibit that SiPc-ddCPP can be rapidly taken up by bacteria but not by normal cells. In summary, SiPc-ddCPP has significant photodynamic/photothermal synergistic antibacterial effects and can be used as bactericide for in situ treatment of bacterial infections.

Conclusions

In summary, an orthogonal conjugated oligomer (SiPc-ddCPP) between silicon phthalocyanine (SiPc-NH2) and porphyrin (ddCPP) was successfully synthesized through covalent amide bond connection with uniform particle size of ~100 nm. Energy transfer from ddCPP to SiPc-NH2 was observed within SiPc-ddCPP as evidenced by both steady and time-resolved fluorescence. The NIR photothermal conversion efficiency (η) of SiPc-ddCPP was calculated to be 31.15%, along with ROS generation and fluorescence emission. Antibacterial experiments showed that SiPc-ddCPP could completely inhibit Gram-positive and Gram-negative anaerobic bacteria in a few minutes under synergistic PTT-PDT effect. Therefore, SiPc-ddCPP is a novel multifunctional NIR bactericide for PDT-PTT synergistic sterilizing of either anaerobic or aerophile bacteria for in situ treatment of bacterial infections.

Experiments

Chemicals and materials

5,15-diphenyl-10,20-di(4-carboxyphenyl)porphine (ddCPP) was purchased from Beijing Huawei Ruike Chemical Co., LTD. Silicon phthalocyanine dichloride (SiPcCl2), 2-(2-aminoethoxy)-ethanol, 1,3-diphenylisobenzofuran (DPBF), 1-(3-(dimethylamino)-propyl)-3-ethylcarbodiimide hydrochloride (EDC·HCl), N-hydroxysuccinimide (NHS), N,N-diisopropylethylamine (DIPEA) were purchased from Sigma-Aldrich. Regenerated cellulose dialysis bag (molecular weight cutoff: 1000) purchased from Shanghai Yuanye Biotechnology Co. All reactions were carried out under a nitrogen atmosphere. Pyridine, toluene and N,N-dimethylformamide were distilled from barium oxide, sodium, magnesium and barium oxide, respectively. All other reagents are of analytical grade purity and no further purification was used.

Characterizations and instruments

Gel permeation chromatography were recorded on an Agilent 1260 Infinity II chromatograph. FT-IR spectra were acquired on a Nicolet NEXUS 670 Fourier transformation infrared (FTIR) spectrometer. The Raman spectra were recorded on a Horbin PHS-3C Raman spectrometer. X-ray-photoelectron spectroscopy (XPS) was performed on a KAlpha X-ray Photoelectron Spectrometer System (ESCALAB 250, Thermo, USA), and C 1 s (284.8 eV) was used to calibrate the peak positions for the elemental analysis. Dynamic light scattering was measured on a Zetasizer Nano ZS, Malvern Panalytical analyzer. Atomic absorption spectra were acquired on a Thermo iCE30000 spectrometer. Ultraviolet visible (UV−vis) spectra were measured on a PerkinElmer Lambda-35 UV−vis spectrometer and the samples were dispersed in H2O or DMF. Steady-state fluorescence spectra were obtained on a Hitachi F-2700 spectrofluorimeter equipped with a 450 W Xe lamp. The time resolved fluorescence spectra were measured using Edinburgh FLS920 spectrometer. Singlet oxygen tests were performed on a 150 W Philips QVF 133 halogen lamp. The photothermal properties were recorded by a Testo 872 infrared thermal imager. Bacterial and cell experimental data were obtained on a 30 W Boxing BS-GS-660nm LED lamp and a 4 W LSR808NL 808 nm laser.

Synthesis

SiPc-NH2 was synthesized according to our previously reported procedure56,57. 5,15-diphenyl-10,20- di(4-carboxyphenyl)porphine (ddCPP) (21.2 mg, 0.03 mmol) was dispersed in a mixed solution of DMF/H2O (v/v 2:3) with ultrasonication. Then, EDC·HCl (46.0 mg, 0.24 mmol) and NHS (27.6 mg, 0.24 mmol) were added to the above solution and stirred for 3 h. Thereafter, SiPc-NH2 (45.0 mg, 0.06 mmol) and DIPEA (315 µL, 1.80 mmol) were added and continued to stir at room temperature under a nitrogen atmosphere for 3 days. The reaction mixture was dialyzed (molecular weight cutoff: 1000) in DMF repetitively for 2 days, and followed by dialysis in deionized water for another 2 days. Then the final product was freeze-dried to give SiPc-ddCPP as a dark powder (22.7 mg, 52.8%).

Singlet oxygen determination

1,3-Diphenylisobenzofuran (DPBF) was used as a scavenger of the singlet oxygen (1O2). The DMF solution containing DPBF (40 μmol) and SiPc-ddCPP solution (6 μmol) was irradiated by red light (λ > 610 nm) or near infrared light (λ = 750 ± 10 nm) from a halogen lamp with corresponding filters. The absorbance of DPBF at 415 nm was recorded every 10 s along with the irradiation. To prevent DPBF from aggregation, Cremophor EL with a volume fraction of 0.1% was added into the aqueous solution.

Photothermal effect measurement

SiPc-ddCPP was dissolved in H2O with sonication to different concentrations. Then, 1 mL of each solution was irradiated by a 671/808 nm laser for 10 min in a quartz cuvette. The temperature change was recorded every 30 s using an infrared thermal imager (testo 872). Equivalent amount of 5,15-diphenyl-10,20-di(4-carboxyphenyl)porphine (ddCPP) and SiPc-NH2 were measured under the same conditions for comparison. The laser-power dependent photothermal effect of SiPc-ddCPP were obtained by 808 nm laser irradiation with different laser power output. Photothermal conversion efficiency (η) of SiPc-ddCPP was measured and calculated according to reported method58.

Photothermal stability

The photothermal stability of SiPc-ddCPP was assessed by repetitive heating with an 808 nm laser for 10 min, followed by natural cooling to room temperature. The photostability was evaluated according to temperature change after several cycles of high-power laser exposure (3.5 W cm-2).

Antibacterial experiment

Gram-positive bacteria Staphylococcus aureus (S. aureus) and Gram-negative bacteria Escherichia coli (E. coli) were used for antibacterial experiments. The bacteria were incubated at 37 °C overnight on agar plates. Then, the bacteria stock solution was prepared at a concentration of 108 bacteria/mL in saline by detecting the absorption at 600 nm (OD600 = 0.213 or 0.413 for S. aureus and E. coli, respectively), which were further diluted with sterilized saline to a concentration of 105 bacteria per mL. Then, the bacterial solution (100 μL) was mixed with different concentrations of SiPc-ddCPP (100 μL) on a 96-well plate and immediately applied to photodynamic/photothermal inhibition test by irradiation with a 660 nm LED lamp (0.2 mW cm-2) or an 808 nm laser (3.0 W cm-2), respectively. Then, the post-irradiation mixture (50 μL) was extracted and evenly dispersed onto agar plate and incubated at 37 °C for 24 h before bacterial colony counting.

Cytotoxicity experiment

Mouse embryonic osteoblasts (MC3T3) were utilized for cytotoxicity evaluation. Cells in 96-well plates (1 × 104 per well) were incubated overnight in DMEM medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin (100 units mL-1, streptomycin 100 μg mL-1, respectively) at 37 °C under 5% CO2 for attachment. The cells were then incubated with different concentrations of SiPc-ddCPP for 24 h to detect dark-toxicity. The cells for irradiation groups incubated with SiPc-ddCPP antibacterial experiment, and then were rinsed with PBS twice and 100 μL of culture medium was added to each well before being illuminated. Then irradiation groups were exposed to 808 nm laser (3.0 W cm-2) or 660 nm lamp (0.2 mW cm-2) or their superposition for 5 min, and cell viability was assessed 24 h after irradiation using CCK-8 assay. Dark groups were acquired under the same conditions without irradiation; the control group was cultured with pure medium.

Related Articles

A method for blood pressure hydrostatic pressure correction using wearable inertial sensors and deep learning

Cuffless noninvasive blood pressure (BP) measurement could enable early unobtrusive detection of abnormal BP patterns, but when the sensor is placed on a location away from heart level (such as the arm), its accuracy is compromised by variations in the position of the sensor relative to heart level; such positional variations produce hydrostatic pressure changes that can cause swings in tens of mmHg in the measured BP if uncorrected. A standard method to correct for changes in hydrostatic pressure makes use of a bulky fluid-filled tube connecting heart level to the sensor. Here, we present an alternative method to correct for variations in hydrostatic pressure using unobtrusive wearable inertial sensors. This method, called IMU-Track, analyzes motion information with a deep learning model; for sensors placed on the arm, IMU-Track calculates parameterized arm-pose coordinates, which are then used to correct the measured BP. We demonstrated IMU-Track for BP measurements derived from pulse transit time, acquired using electrocardiography and finger photoplethysmography, with validation data collected across 20 participants. Across these participants, for the hand heights of 25 cm below or above the heart, mean absolute errors were reduced for systolic BP from 13.5 ± 1.1 and 9.6 ± 1.1 to 5.9 ± 0.7 and 5.9 ± 0.5 mmHg, respectively, and were reduced for diastolic BP from 15.0 ± 1.0 and 11.5 ± 1.5 to 6.8 ± 0.5 and 7.8 ± 0.8, respectively. On a commercial smartphone, the arm-tracking inference time was ~134 ms, sufficiently fast for real-time hydrostatic pressure correction. This method for correcting hydrostatic pressure may enable accurate passive cuffless BP monitors placed at positions away from heart level that accommodate everyday movements.

Energy metabolism in health and diseases

Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Macrophages are immune cells belonging to the mononuclear phagocyte system. They play crucial roles in immune defense, surveillance, and homeostasis. This review systematically discusses the types of hematopoietic progenitors that give rise to macrophages, including primitive hematopoietic progenitors, erythro-myeloid progenitors, and hematopoietic stem cells. These progenitors have distinct genetic backgrounds and developmental processes. Accordingly, macrophages exhibit complex and diverse functions in the body, including phagocytosis and clearance of cellular debris, antigen presentation, and immune response, regulation of inflammation and cytokine production, tissue remodeling and repair, and multi-level regulatory signaling pathways/crosstalk involved in homeostasis and physiology. Besides, tumor-associated macrophages are a key component of the TME, exhibiting both anti-tumor and pro-tumor properties. Furthermore, the functional status of macrophages is closely linked to the development of various diseases, including cancer, autoimmune disorders, cardiovascular disease, neurodegenerative diseases, metabolic conditions, and trauma. Targeting macrophages has emerged as a promising therapeutic strategy in these contexts. Clinical trials of macrophage-based targeted drugs, macrophage-based immunotherapies, and nanoparticle-based therapy were comprehensively summarized. Potential challenges and future directions in targeting macrophages have also been discussed. Overall, our review highlights the significance of this versatile immune cell in human health and disease, which is expected to inform future research and clinical practice.

Photothermal sensitive nanocomposite hydrogel for infectious bone defects

Infectious bone defects represent a substantial challenge in clinical practice, necessitating the deployment of advanced therapeutic strategies. This study presents a treatment modality that merges a mild photothermal therapy hydrogel with a pulsed drug delivery mechanism. The system is predicated on a hydrogel matrix that is thermally responsive, characteristic of bone defect sites, facilitating controlled and site-specific drug release. The cornerstone of this system is the incorporation of mild photothermal nanoparticles, which are activated within the temperature range of 40–43 °C, thereby enhancing the precision and efficacy of drug delivery. Our findings demonstrate that the photothermal response significantly augments the localized delivery of therapeutic agents, mitigating systemic side effects and bolstering efficacy at the defect site. The synchronized pulsed release, cooperated with mild photothermal therapy, effectively addresses infection control, and promotes bone regeneration. This approach signifies a considerable advancement in the management of infectious bone defects, offering an effective and patient-centric alternative to traditional methods. Our research endeavors to extend its applicability to a wider spectrum of tissue regeneration scenarios, underscoring its transformative potential in the realm of regenerative medicine.

Responses

Your email address will not be published. Required fields are marked *